Literature DB >> 12832964

Management and outcome of patients with sporadic gastrinoma arising in the duodenum.

Theresa G Zogakis1, Fathia Gibril, Steven K Libutti, Jeffrey A Norton, Donald E White, Robert T Jensen, H Richard Alexander.   

Abstract

BACKGROUND: Primary duodenal gastrinomas are now recognized as a common etiology for patients with sporadic Zollinger Ellison Syndrome (ZES); however, the clinical and pathologic features of this condition and long-term outcome after operation are not well characterized.
METHODS: Between November 1982 and September 2000, 63 patients diagnosed with sporadic ZES underwent resection of a primary duodenal gastrinoma and regional nodal metastases with curative intent. Data from a prospectively maintained database were reviewed for clinical and pathologic parameters relating to primary tumor size, location, frequency of lymph node metastases, and disease-specific and disease-free survival.
RESULTS: There were 41 males and 22 females (mean age, 48.6 years). The majority of duodenal gastrinomas were in the first or second portions of the duodenum (83%). Tumor size ranged from 0.2 to 2.0 cm with 62% measuring less than 1.0 cm. Sixty percent of individuals had regional lymph node metastases identified primarily in proximity to the primary tumor. At a median 10-year follow-up, the overall disease-specific and disease-free survivals were 100% and 60%, respectively. Actuarial 10-year disease-free survival was significantly higher for patients without lymph node metastases versus those with lymph node metastases (78% versus 48%, P = 0.0137).
CONCLUSIONS: Duodenal gastrinomas in patients with sporadic ZES are frequently small, most commonly located in the proximal duodenum, and associated with regional lymph node metastases in 60%. Disease-free survival is lower for patients with regional lymph node metastases suggesting that a more systematic lymphadenectomy to extirpate occult disease may be indicated in this group.

Entities:  

Mesh:

Year:  2003        PMID: 12832964      PMCID: PMC1422657          DOI: 10.1097/01.SLA.0000074963.87688.31

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  21 in total

1.  Intraoperative ultrasonographic localization of islet cell tumors. A prospective comparison to palpation.

Authors:  J A Norton; D T Cromack; T H Shawker; J L Doppman; R Comi; P Gorden; P N Maton; J D Gardner; R T Jensen
Journal:  Ann Surg       Date:  1988-02       Impact factor: 12.969

2.  Localization, malignant potential, and surgical management of gastrinomas.

Authors:  O Kisker; D Bastian; D Bartsch; C Nies; M Rothmund
Journal:  World J Surg       Date:  1998-07       Impact factor: 3.352

Review 3.  Endocrine cells of the gastrointestinal tract and related tumors.

Authors:  E Solcia; C Capella; R Buffa; L Usellini; B Frigerio; P Fontana
Journal:  Pathobiol Annu       Date:  1979

4.  Duodenal wall tumors and the Zollinger-Ellison syndrome. Surgical management.

Authors:  J W Hofmann; P S Fox; S D Wilson
Journal:  Arch Surg       Date:  1973-08

5.  Thirty years' experience with gastrinoma.

Authors:  R M Zollinger; E C Ellison; T M O'Dorisio; J Sparks
Journal:  World J Surg       Date:  1984-08       Impact factor: 3.352

Review 6.  Intraoperative methods to stage and localize pancreatic and duodenal tumors.

Authors:  J A Norton
Journal:  Ann Oncol       Date:  1999       Impact factor: 32.976

7.  Surgery to cure the Zollinger-Ellison syndrome.

Authors:  J A Norton; D L Fraker; H R Alexander; D J Venzon; J L Doppman; J Serrano; S U Goebel; P L Peghini; P K Roy; F Gibril; R T Jensen
Journal:  N Engl J Med       Date:  1999-08-26       Impact factor: 91.245

8.  Prospective study of the ability of computed axial tomography to localize gastrinomas in patients with Zollinger-Ellison syndrome.

Authors:  S A Wank; J L Doppman; D L Miller; M J Collen; P N Maton; R Vinayek; J I Slaff; J A Norton; J D Gardner; R T Jensen
Journal:  Gastroenterology       Date:  1987-04       Impact factor: 22.682

9.  Long-term treatment with lansoprazole for patients with Zollinger-Ellison syndrome.

Authors:  B I Hirschowitz; J Mohnen; S Shaw
Journal:  Aliment Pharmacol Ther       Date:  1996-08       Impact factor: 8.171

10.  Benign and malignant gastrinoma.

Authors:  B E Stabile; E Passaro
Journal:  Am J Surg       Date:  1985-01       Impact factor: 2.565

View more
  17 in total

Review 1.  Surgical treatment of gastrointestinal neuroendocrine tumors.

Authors:  Volker Fendrich; Detlef K Bartsch
Journal:  Langenbecks Arch Surg       Date:  2011-02-01       Impact factor: 3.445

2.  [Rare occurrence of fulminant acid burn of the esophagus].

Authors:  C Knebel; R Bumm; K Becker; M Burian; J R Siewert
Journal:  Chirurg       Date:  2008-08       Impact factor: 0.955

3.  Recurrent gastrinoma in the mesentery 19 years after primary resection.

Authors:  Keiko Nishio; Akiyoshi Nishio; Toshikuni Nishikawa; Yoichiro Kobashi; Satoru Matsusue
Journal:  Dig Dis Sci       Date:  2007-04-10       Impact factor: 3.199

Review 4.  Changing treatment strategy for gastrinoma in patients with Zollinger-Ellison syndrome.

Authors:  Masayuki Imamura; Izumi Komoto; Shuichi Ota
Journal:  World J Surg       Date:  2006-01       Impact factor: 3.352

Review 5.  Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management, and controversies.

Authors:  Robert T Jensen; Marc J Berna; David B Bingham; Jeffrey A Norton
Journal:  Cancer       Date:  2008-10-01       Impact factor: 6.860

6.  [Zollinger-Ellison syndrome].

Authors:  V Fendrich; D K Bartsch; P Langer; A Zielke; M Rothmund
Journal:  Chirurg       Date:  2005-03       Impact factor: 0.955

7.  Does the use of routine duodenotomy (DUODX) affect rate of cure, development of liver metastases, or survival in patients with Zollinger-Ellison syndrome?

Authors:  Jeffrey A Norton; H Richard Alexander; Douglas L Fraker; David J Venzon; Fathia Gibril; Robert T Jensen
Journal:  Ann Surg       Date:  2004-05       Impact factor: 12.969

8.  Syndromic versus non-syndromic sporadic gastrin-producing neuroendocrine tumors of the duodenum: comparison of pathological features and biological behavior.

Authors:  M Johannes Rosentraeger; Nele Garbrecht; Martin Anlauf; Andreas Raffel; Wolfram T Knoefel; Bertram Wiedenmann; Günter Klöppel
Journal:  Virchows Arch       Date:  2015-12-09       Impact factor: 4.064

Review 9.  Surgical management of pancreatic endocrine tumors.

Authors:  Volker Fendrich; Jens Waldmann; Detlef K Bartsch; Peter Langer
Journal:  Nat Rev Clin Oncol       Date:  2009-06-09       Impact factor: 66.675

10.  A Multi-institutional Analysis of Duodenal Neuroendocrine Tumors: Tumor Biology Rather than Extent of Resection Dictates Prognosis.

Authors:  Georgios Antonios Margonis; Mario Samaha; Yuhree Kim; Lauren McLendon Postlewait; Pamela Kunz; Shishir Maithel; Thuy Tran; Nickolas Berger; T Clark Gamblin; Matthew G Mullen; Todd W Bauer; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2016-03-23       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.